Impact of Atypical Antipsychotics as Adjunctive Therapy on Psychiatric Cost and Utilization in Patients with Major Depressive Disorder

INTRODUCTION: Patients with major depressive disorder (MDD) incur high costs, despite established treatment options. Adding an atypical antipsychotic (AAP) to antidepressant therapy has shown to reduce depressive symptoms in MDD, but it remains unclear with which adjunctive AAP to initiate. As econo...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clinicoecon Outcomes Res
Auteurs principaux: Yan, Tingjian, Greene, Mallik, Chang, Eunice, Houle, Christy R, Tarbox, Marian H, Broder, Michael S
Format: Artigo
Langue:Inglês
Publié: Dove 2020
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7012250/
https://ncbi.nlm.nih.gov/pubmed/32104020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S231824
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires